Viewing Study NCT06570603



Ignite Creation Date: 2024-10-26 @ 3:38 PM
Last Modification Date: 2024-10-26 @ 3:38 PM
Study NCT ID: NCT06570603
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-05-07

Brief Title: Targeting Components of Distress Tolerance
Sponsor: None
Organization: None

Study Overview

Official Title: Targeting Components of Distress Tolerance
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to learn which aspects of distress intolerance ie difficulties withstanding upsetting emotional states are the most important for improving effective emotion regulation and associated mental health symptoms

The main questions it aims to answer are

How are willingness to feel upset and self-efficacy for withstanding distress associated with different emotion regulation strategies used in daily life

Does targeting willingness to feel upset andor self-efficacy for withstanding distress help people use more effective emotion regulation strategies in daily life when they feel upset

Are improvements in emotion regulation strategies in daily life associated with fewer symptoms of mental health problems over time

Participants will

Answer questions about their moods willingness to feel upset self-efficacy for withstanding distress and emotion regulation strategies for three weeks using a cell phone app

Undergo a willingness self-efficacy combined or psychoeducational control intervention in the lab

Be prompted to use the intervention skill via the cell phone app during the second week after the intervention

Complete weekly reports of mental health symptoms
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None